Telomir Pharmaceuticals raises $5.6M
- Closed on Oct 5, 2026
- Issued 4,843,300 shares at $1.16
- John Paul DeJoria invested $1M
TELO
Telomir Pharmaceuticals, Inc. SEC filings
Every EDGAR filing for Telomir Pharmaceuticals, Inc. (TELO), newest first, with AI summaries and stories.
- Ticker
- TELO
- CIK
- 1971532
- Sector
- Biotech and pharma
- Latest filing
- Oct 6
Next: 10-Q expected ~Nov 13 (deadline Nov 16)
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
ROUTINE8-KTelomir Pharmaceuticals, Inc.TELOLIVE ROUTINE8-KTelomir Pharmaceuticals, Inc.TELOLIVE ROUTINE8-KTelomir Pharmaceuticals, Inc.TELOLIVE ROUTINE8-KTelomir Pharmaceuticals, Inc.TELOLIVE ROUTINEDEFA14ATelomir Pharmaceuticals, Inc.TELOLIVE ROUTINESCHEDULE 13G/ATelomir Pharmaceuticals, Inc.TELOLIVE Ownership stake disclosure by John Paul Dejoria (amended)
John Paul Dejoria, filed by
NOTABLE10-QTelomir Pharmaceuticals, Inc.TELOLIVE ROUTINE8-KTelomir Pharmaceuticals, Inc.TELOLIVE ROUTINEDEF 14ATelomir Pharmaceuticals, Inc.TELOLIVE ROUTINE4Telomir Pharmaceuticals, Inc.TELOLIVE 3 insider filings
Giudice Matthew Paul Del, insider filing for TELO
Show all 3
- 4Insider filing for TELO
- 4Insider filing for TELO
- 4Insider filing for TELO
Giudice Matthew Paul Del, reporting
ROUTINE8-KTelomir Pharmaceuticals, Inc.TELOLIVE ROUTINE3Telomir Pharmaceuticals, Inc.TELOLIVE Andriy Mushak, new insider at TELO
Andriy Mushak, reporting
ROUTINE8-KTelomir Pharmaceuticals, Inc.TELOLIVE ROUTINE4Telomir Pharmaceuticals, Inc.TELOLIVE 4 insider filings
Edward Clouston MacPherson, insider filing for TELO
Show all 4
- 4Insider filing for TELO
- 4Insider filing for TELO
- 4Insider filing for TELO
- 4Insider filing for TELO
Edward Clouston MacPherson, reporting
ROUTINE8-KTelomir Pharmaceuticals, Inc.TELOLIVE NOTABLE10-QTelomir Pharmaceuticals, Inc.TELOLIVE ROUTINE8-KTelomir Pharmaceuticals, Inc.TELOLIVE ROUTINE4Telomir Pharmaceuticals, Inc.TELOLIVE Erez Aminov, insider filing for TELO
Erez Aminov, reporting
ROUTINE8-KTelomir Pharmaceuticals, Inc.TELOLIVE ROUTINE8-KTelomir Pharmaceuticals, Inc.TELOLIVE ROUTINE8-KTelomir Pharmaceuticals, Inc.TELOLIVE ROUTINE8-KTelomir Pharmaceuticals, Inc.TELOLIVE NOTABLE10-KTelomir Pharmaceuticals, Inc.TELOLIVE NOTABLEDEFM14ATelomir Pharmaceuticals, Inc.TELOLIVE ROUTINEDEFA14ATelomir Pharmaceuticals, Inc.TELOLIVE ROUTINE8-KTelomir Pharmaceuticals, Inc.TELOLIVE ROUTINESCHEDULE 13G/ATelomir Pharmaceuticals, Inc.TELOLIVE Ownership stake disclosure by John Paul Dejoria (amended)
John Paul Dejoria, filed by
ROUTINE8-KTelomir Pharmaceuticals, Inc.TELOLIVE ROUTINEPRER14ATelomir Pharmaceuticals, Inc.TELOLIVE ROUTINE8-KTelomir Pharmaceuticals, Inc.TELOLIVE ROUTINE8-KTelomir Pharmaceuticals, Inc.TELOLIVE ROUTINEPRER14ATelomir Pharmaceuticals, Inc.TELOLIVE ROUTINE8-KTelomir Pharmaceuticals, Inc.TELOLIVE Telomir Pharmaceuticals, Inc. reported: Other Events
- Item 8.01 Other Events
MAJOR8-KTelomir Pharmaceuticals, Inc.TELOLIVE Telomir Pharmaceuticals, Inc. reported: Departure of Directors or Certain Officers.
- Item 5.02. Departure of Directors or Certain Officers.
- Item 9.01(d) Financial Statements and Exhibits.
NOTABLEPREM14ATelomir Pharmaceuticals, Inc.TELOLIVE Telomir Pharmaceuticals, Inc. filed PREM14A
- Form Type: PREM14A
- Filing Date: 2025-11-20
ROUTINE8-KTelomir Pharmaceuticals, Inc.TELOLIVE Telomir Pharmaceuticals, Inc. reported: Other Events
- Item 8.01 Other Events
ROUTINE8-KTelomir Pharmaceuticals, Inc.TELOLIVE NOTABLE10-QTelomir Pharmaceuticals, Inc.TELOLIVE